WEE1 and colonic neoplasm: Inhibition of WEE1 by the selective WEE1 inhibitor MK-1775 resulted in anti-tumor effects in several preclinical tumor models including colon cancer, suggesting WEE1 as a potential therapeutic target for anticancer treatment (62).